drugset / Trial / NCT00704782

Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

NCT00704782

Phase 2 Terminated 50 enrolled Medivation, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.

Timeline

Start
2008-04
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Latrepirdine Small molecule 20 mg Oral

Indications